Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA).
Maryam OskouiJohn W DayNicolas DeconinckElena Stacy MazzoneAndres NascimentoKayoko SaitoCarole VuillerotGiovanni BaranelloNathalie GoemansJanbernd KirschnerMaria JędrzejowskaLaurent ServaisGergely PappKsenija GorniHeidemarie KletzlCarmen MartinTammy McIverRenata S ScalcoHannah StauntonWai Yin YeungPaulo FontouraEugenio Mercurinull nullPublished in: Journal of neurology (2023)
Keyphrases